Calcium+Company welcomes Anna Kotis as Chief of Advertising and other senior talent to the executive team March 5, 2026
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026 March 5, 2026
Johnny Huard, Ph.D., Chief Scientific Officer of Steadman Philippon Research Institute (SPRI) Receives Second Annual Arnold I. Caplan Award March 5, 2026
authID Selected by Top Financial Platform Serving More Than 100 Banks, to Provide Biometric Verification for Banking Customers March 5, 2026
Entrée Resources Announces Fiscal Year 2025 Results and Reviews Q4 Corporate Highlights March 5, 2026
New Survey Reveals Over Half of Americans Delayed Healthcare in Past Year, Citing Cost and Schedule Conflicts as Primary Barriers March 5, 2026
Starton Therapeutics Files Patent Applications for the Use of CAR-T Cell Therapies in Combination with its Proprietary, Continuous Low-Dose Immunomodulatory Therapy, STAR-LLD, a formulation of Lenalidomide, for the Treatment of Blood Cancer March 5, 2026
Kestrel Therapeutics Announces IND Clearance by U.S. FDA of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, Enabling Initiation of Phase 1 Trial March 5, 2026
Delinea Completes StrongDM Acquisition to Secure AI Agents with Continuous Identity Authorization March 5, 2026